Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
5,452.00
4,648.00
4,208.00
3,742.00
3,340.00
2,889.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
5,452.00
4,648.00
4,208.00
3,742.00
3,340.00
2,889.00
Expenditure (Ex Depriciation)
Stock Adjustments
37.00
-25.00
-39.00
25.00
-83.00
-150.00
Raw Materials Consumed
1,146.00
1,096.00
1,105.00
1,024.00
915.00
795.00
Power & Fuel Cost
73.00
70.00
66.00
65.00
54.00
43.00
Employee Cost
1,291.00
1,089.00
900.00
785.00
645.00
548.00
Operating Expenses
223.00
199.00
168.00
185.00
170.00
119.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
651.00
482.00
417.00
463.00
400.00
374.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
204.00
96.00
85.00
87.00
56.00
50.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
4,058.00
3,388.00
3,036.00
2,959.00
2,411.00
1,891.00
Operating Profit (PBDIT) excl Other Income
1,394.00
1,259.00
1,171.00
783.00
929.00
998.00
Other Income
172.00
94.00
84.00
98.00
115.00
25.00
Operating Profit (PBDIT)
1,566.00
1,354.00
1,256.00
881.00
1,044.00
1,024.00
Interest
16.00
20.00
7.00
5.00
10.00
8.00
Profit before Depriciation and Tax
1,550.00
1,333.00
1,249.00
876.00
1,034.00
1,016.00
Depreciation
173.00
144.00
135.00
130.00
125.00
116.00
Profit Before Taxation & Exceptional Items
1,377.00
1,189.00
1,113.00
745.00
909.00
900.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,377.00
1,189.00
1,113.00
745.00
909.00
900.00
Provision for Tax
321.00
268.00
297.00
157.00
196.00
246.00
Profit After Tax
1,056.00
920.00
816.00
587.00
712.00
653.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
3,671.00
3,314.00
3,141.00
2,717.00
2,155.00
1,617.00
Profit Available for appropriations
4,727.00
4,234.00
3,957.00
3,305.00
2,868.00
2,271.00
Appropriations
4,727.00
4,234.00
3,957.00
3,305.00
2,868.00
2,271.00
Equity Dividend (%)
1,400.00%
1,400.00%
2,550.00%
350.00%
475.00%
475.00%
Earnings Per Share
84.53
73.56
64.82
45.89
54.97
75.09
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 17.31% vs 10.44% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 10.74% vs 7.47% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -22.29% vs 187.52% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 14.73% vs 12.77% in Mar 2025
Compare Profit and Loss Results of Ajanta Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
5,452.00
3,821.00
1,631.00
42.69%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5,452.00
3,821.00
1,631.00
42.69%
Expenditure (Ex Depriciation)
Stock Adjustments
37.00
4.00
33.00
825.00%
Raw Materials Consumed
1,146.00
1,346.00
-200.00
-14.86%
Power & Fuel Cost
73.00
30.00
43.00
143.33%
Employee Cost
1,291.00
607.00
684.00
112.69%
Operating Expenses
223.00
101.00
122.00
120.79%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
651.00
178.00
473.00
265.73%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
204.00
55.00
149.00
270.91%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
4,058.00
2,512.00
1,546.00
61.54%
Operating Profit (PBDIT) excl Other Income
1,394.00
1,309.00
85.00
6.49%
Other Income
172.00
145.00
27.00
18.62%
Operating Profit (PBDIT)
1,566.00
1,454.00
112.00
7.70%
Interest
16.00
2.00
14.00
700.00%
Profit before Depriciation and Tax
1,550.00
1,451.00
99.00
6.82%
Depreciation
173.00
66.00
107.00
162.12%
Profit Before Taxation & Exceptional Items
1,377.00
1,385.00
-8.00
-0.58%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,377.00
1,406.00
-29.00
-2.06%
Provision for Tax
321.00
370.00
-49.00
-13.24%
Profit After Tax
1,056.00
1,035.00
21.00
2.03%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,671.00
1,058.00
2,613.00
246.98%
Profit Available for appropriations
4,727.00
2,094.00
2,633.00
125.74%
Appropriations
4,727.00
2,094.00
2,633.00
125.74%
Equity Dividend (%)
1400%
570%
830.00
Earnings Per Share
84.53
61.15
23.38
38.23%
Profit And Loss - Net Sales
Net Sales 5,452.86 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.31% vs 10.44% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,394.83 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.74% vs 7.47% in Mar 2025
Profit And Loss - Interest
Interest 16.11 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -22.29% vs 187.52% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 1,056.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 14.73% vs 12.77% in Mar 2025






